Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Particle Characterization and Rheology Systems

By Drug Discovery Trends Editor | January 29, 2009

Malvern's KinexusMalvern will feature a new range of particle characterization and rheology systems, and a new Viscotek chromatography product, at Pittcon 2009. Malvern’s Kinexus rotational rheometer, Zetasizer APS and Zetasizer µV particle characterization systems, and a new application for the Morphologi G3, will be on display. The launch of a new detector for the Viscotek TDAmax gel permeation chromatography system also celebrates the first anniversary of Malvern’s acquisition of the company. 

Malvern’s Kinexus is a rotational rheometer platform. It incorporates technological innovations in rheometer design, from sample preparation and loading, through measurement set-up and operation, to data analysis and reporting. Adaptive intelligence allows Kinexus to actively guide users at every stage.

The Zetasizer APS, a dynamic light scattering system, automates size measurements of Malvern's Zetasizer APSsamples in 96- or 384-well microplates. Designed for protein specialists, the system is fully automated, requiring users to insert the plate and press start. It allows for investigation of a protein’s condition at different stages of the purification process, and at later stages of formulation under a range of environmental conditions.

Malvern's Zetasizer µVThe Zetasizer µV is an advanced light scattering system intended for the characterization of proteins and other biomolecules. Requiring just two microlitres of sample, it enables measurement of as little as 40 nanograms of BSA (bovine serum albumin) for example. This system supports improved understanding and management of a wide range of biomolecule applications. Malvern's Morphologi G3 

A new capability for the Morphologi G3 particle characterization system enables the fully automated detection, enumeration, and size classification of foreign particulate matter collected on a filter. Traditionally this has been the preserve of manual light microscopy. Now the Morphologi G3 brings fully automated image analysis to accelerate characterization and remove any operator subjectivity.

Visit Malvern at booth #2027 at Pittcon 2009.

www.malvern.com


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE